Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Nusa Raya Cipta Tbk. (NRCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Nusa Raya Cipta Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Nusa Raya Cipta Tbk. trades at Rp530 (market cap 1.32T, 9.53M 24h volume). The key difference: Nusa Raya Cipta Tbk. is far larger — about 4.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Nusa Raya Cipta Tbk. is more actively traded (9.53M versus 41.7K). Which is the better fit depends on your goals.
| DGNS | NRCA | |
|---|---|---|
Market Cap | 316.25B | 1.32T |
Volume | 41.7K | 9.53M |
Lot | 417 | 95.29K |
Turnover | 9.66M | 5.07B |
Average Price | 231.65 | 531.64 |
Value | 9.66M | 5.07B |
Indicative Equilibrium Price | 230 | 530 |
Indicative Equilibrium Volume | 2.4K | 257 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Nusa Raya Cipta Tbk.
PT Nusa Raya Cipta Tbk (the Company) was establised based on notarial deed No. 134 of Ny Kartini Muljadi, SH., dated September 17, 1975.
Read more on NRCA →
